1
Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc, REID Scott W, May 4, 2006: WO/2006/047516 (17 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


2
Sim Taebo, Nguyen Truc Ngoc, Wu Baogen, He Yun, Xie Yongping, Wang Xing, Zhang Guobao, Gray Nathanael S: Protein kinase inhibitors and methods for using thereof. Irm, Sim Taebo, Nguyen Truc Ngoc, Wu Baogen, He Yun, Xie Yongping, Wang Xing, Zhang Guobao, Gray Nathanael S, TONGCO WU Emily, December 24, 2008: WO/2008/157575 (15 worldwide citation)

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, and methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provid ...


3
Chen Bei, Jiang Tao, Marsilje Thomas H, Michellys Pierre Yves, Nguyen Truc Ngoc, Pei Wei, Wu Baogen, Gao Zhaobo, Ge Yonghui, Huang Chen, Li Yuncheng: Compounds and compositions as protein kinase inhibitors. Irm, Novartis, Chen Bei, Jiang Tao, Marsilje Thomas H, Michellys Pierre Yves, Nguyen Truc Ngoc, Pei Wei, Wu Baogen, Gao Zhaobo, Ge Yonghui, Huang Chen, Li Yuncheng, sTONGO WU Emily, October 15, 2009: WO/2009/126515 (13 worldwide citation)

The invention provides novel pyrimidine derivatives and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kina ...


4
He Yun, Ellis David Archer, Anaclerio Beth Marie, Kuhen Kelli L, Wu Baogen, Jiang Tao: Quinolones with anti-hiv activity. Irm, He Yun, Ellis David Archer, Anaclerio Beth Marie, Kuhen Kelli L, Wu Baogen, Jiang Tao, MANN Jeffry S, May 6, 2004: WO/2004/037853 (12 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using quinolones and compounds related to quinolones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of proph ...


5
Ren Pingda, Wu Baogen, Zhang Guobao, Xie Yongping, Okram Barun, Nikulin Victor, Wang Xia, Choi Ha Soon: Compounds and compositions as protein kinase inhibitors. Irm, Ren Pingda, Wu Baogen, Zhang Guobao, Xie Yongping, Okram Barun, Nikulin Victor, Wang Xia, Choi Ha Soon, REID Scott W, November 22, 2007: WO/2007/134259 (12 worldwide citation)

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal act ...


6
Azimioara Mihai, Cow Christopher, Epple Robert, Jiang Songchun, Lelais Gerald, Mutnick Daniel, Wu Baogen: Compounds and compositions as modulators of gpr119 activity. Irm, Azimioara Mihai, Cow Christopher, Epple Robert, Jiang Songchun, Lelais Gerald, Mutnick Daniel, Wu Baogen, REID Scottet al, August 27, 2009: WO/2009/105717 (11 worldwide citation)

The invention provides compounds of Formula (I): pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119.


7
He Yun, Wang Zhiwei, Wu Baogen: Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors. Irm, He Yun, Wang Zhiwei, Wu Baogen, SMITH Timothy L, June 19, 2008: WO/2008/073138 (11 worldwide citation)

Described herein are compounds having a terephthalamate structural feature. Also described herein, are methods of making such compounds, methods of using such compounds to modulate the activity of HIV integrase, and pharmaceutical compositions and medicaments comprising such compounds. Also describe ...


8
Liu Hong, He Xiaohui, Phillips Dean, Zhu Xuefeng, Yang Kunyong, Lau Thomas, Wu Baogen, Xie Yongping, Nguyen Truc Ngoc, Wang Xing: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Liu Hong, He Xiaohui, Phillips Dean, Zhu Xuefeng, Yang Kunyong, Lau Thomas, Wu Baogen, Xie Yongping, Nguyen Truc Ngoc, Wang Xing, REID Scott W, June 26, 2008: WO/2008/076754 (9 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


9
Jiang Tao, Michellys Pierre Yves, Nguyen Truc Ngoc, Pei Wei, Wu Baogen, Zhu Xuefeng: Compounds and compositions as kinase inhibitors. Irm, Jiang Tao, Michellys Pierre Yves, Nguyen Truc Ngoc, Pei Wei, Wu Baogen, Zhu Xuefeng, TONGO WU Emily, October 15, 2009: WO/2009/126514 (8 worldwide citation)

The invention relates to triazine and pyrimidine derivatives having Formula (1) or (2), and methods for using such compounds. For example, the compounds of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of anaplastic lymphoma kinase (ALK) activity, ...


10
Wu Baogen, He Yun, Ngyuen Truc, Kuhen Kelli L, Ellis David Archer, Jiang Tao: Pyrrolidones with anti-hiv activity. Irm, Wu Baogen, He Yun, Ngyuen Truc, Kuhen Kelli L, Ellis David Archer, Jiang Tao, MANN Jeffry S, May 6, 2004: WO/2004/037784 (6 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using pyrrolidones and compounds related to pyrrolidones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of p ...